# Andrew Feinberg

> Andrew Feinberg is the president and CEO of BostonGene and chairman and CEO of Netcracker Technology, an unusual dual brief that spans precision oncology and telecom software. After beginning in strategy consulting and joining Netcracker in 1998, he built a career around large, complex data systems, then co-founded BostonGene in 2015 to apply a similar operating logic to multimodal biological data. BostonGene raised a $150 million Series B in 2022, formed a Japan joint venture in 2023, and has expanded through biopharma and academic collaborations.

- **Role:** President and CEO at BostonGene; Chairman and CEO at Netcracker Technology
- **Organizations:** BostonGene, Netcracker Technology, Bain & Company, NEC Corporation
- **Education:** Bachelor's degree, Bentley University, Master of Business Administration, The Wharton School, University of Pennsylvania
- **Known for:** Led BostonGene through a $150 million Series B financing in 2022., Helped establish BostonGene Japan with NEC Corporation and Japan Industrial Partners in 2023., Built a leadership career spanning enterprise telecom software and AI-enabled biotechnology.

## Career timeline

- **1997-1998** — Worked as a consultant at Bain & Company, including work related to telecommunications, software and hardware.
- **1998** — Joined Netcracker Technology and became part of its senior leadership.
- **2015** — Co-founded BostonGene as an investor and operator.
- **2019** — Became president and CEO of BostonGene.
- **2021** — Became chairman and CEO of Netcracker Technology after serving as president and CEO.
- **2022** — BostonGene completed a $150 million Series B led by NEC Corporation.
- **2023** — BostonGene, NEC and Japan Industrial Partners formed BostonGene Japan Inc.
- **2026** — Delivered a Mobile World Congress Barcelona keynote on governing AI at scale.

## Achievements

- Led BostonGene through a $150 million Series B financing in 2022.
- Helped establish BostonGene Japan with NEC Corporation and Japan Industrial Partners in 2023.
- Built a leadership career spanning enterprise telecom software and AI-enabled biotechnology.
- Received the TM Forum Chairman's Award for Netcracker's contribution to the forum.
- Led BostonGene when it was named Overall AI-based Analytics Company of the Year in the 2026 AI Breakthrough Awards.
- Led BostonGene when it received the Life Sciences Times Vanguard Innovator of the Year recognition announced in 2026.

## Latest updates

- **2026-08** — BostonGene was named an Outstanding Organization and double winner in the 2026 Artificial Intelligence Excellence Awards.
- **2026-07** — BostonGene was named Overall AI-based Analytics Company of the Year in the 2026 AI Breakthrough Awards.
- **2026-03** — Feinberg delivered a Mobile World Congress Barcelona keynote focused on governing AI at scale.
- **2026-03** — BostonGene announced its Innovator of the Year recognition from the Life Sciences Times Vanguard Awards.
- **2026-02** — BostonGene announced a strategic collaboration with Johnson & Johnson focused on AI-supported treatment sequencing research.

## Links

- Website: https://bostongene.com
- LinkedIn: https://www.linkedin.com/in/andrewfeinbergceo
- Twitter/X: https://twitter.com/BostonGeneCorp
- YouTube: https://www.youtube.com/channel/UCvu9tWwr-xyI1O9QM314NCw
- Facebook: https://www.facebook.com/BostonGeneCorp

---

Profile page: https://yespress.io/andrew-feinberg
Published by YesPress — https://yespress.io
Last updated: 2026-08-28